Unknown

Dataset Information

0

Zinc enhances temozolomide cytotoxicity in glioblastoma multiforme model systems.


ABSTRACT: Temozolomide (TMZ) is an alkylating agent that has become the mainstay treatment of the most malignant brain cancer, glioblastoma multiforme (GBM). Unfortunately only a limited number of patients positively respond to it. It has been shown that zinc metal reestablishes chemosensitivity but this effect has not been tested with TMZ. Using both in vitro and in vivo experimental approaches, we investigated whether addition of zinc to TMZ enhances its cytotoxicity against GBM. In vitro cell viability analysis showed that the cytotoxic activity of TMZ was substantially increased with addition of zinc and this response was accompanied by an elevation of p21, PUMA, BAX and Caspase-3 expression and a decrease in growth fraction as manifested by low ki67 and lower colony formation. Analysis of GBM as intracranial xenografts in athymic mice and administration of concurrent TMZ and zinc yielded results consistent with those of the in vitro analyses. The co-treatment resulted in significant reduction in tumor volume in TMZ/zinc treated mice relative to treatment with TMZ alone. Our results suggest that zinc may serve as a potentiator of TMZ therapy in GBM patients.

SUBMITTER: Toren A 

PROVIDER: S-EPMC5342707 | BioStudies | 2016-01-01T00:00:00Z

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2987557 | BioStudies
2014-01-01 | S-EPMC4111895 | BioStudies
1000-01-01 | S-EPMC5762574 | BioStudies
2015-01-01 | S-EPMC4330129 | BioStudies
2012-01-01 | S-EPMC4005329 | BioStudies
2019-01-01 | S-EPMC7016639 | BioStudies
2014-01-01 | S-EPMC4119546 | BioStudies
1000-01-01 | S-EPMC3248301 | BioStudies
2019-01-01 | S-EPMC6469146 | BioStudies
2012-01-01 | S-EPMC3424214 | BioStudies